Clinical Trial Update: Safety and Efficacy of Bevacizumab in Combination With Carboplatin and Paclitaxel for Metastatic, Recurrent or Persistent Cervical Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating bevacizumab with carboplatin and paclitaxel for metastatic, recurrent, or persistent cervical cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Cervical Cancer | Phase 2 | Status: COMPLETED